- Management team
- Our founders
- The Board of Directors
- The Executive Committee
- The IHU Board
- Scientific Council
The management
Professor Stéphane Hatem has been Chief Executive Officer of the IHU ICAN since 2018. He was unanimously reappointed by the Board of Directors on 16 December 2021 for a 4-year term.
He is assisted by Stéphane Barritault, General Secretary, in charge of the Institute’s operational management.
This duo at the helm of the IHU is supported by a management committee made up of 6 divisions:
- Innovation and Research Development
- Platforms and Business Development
- Clinical Research: MRI & Corelab Imaging Platform and Cardiometabolic Diseases Clinical Investigation Platform
- Legal, Compliance and Data Policy Division
- Administration, HR and Finance
- Communication and Sponsorship
Joëlle Pfeffer: Executive Assistant
Our founders
To carry out its mission, the IHU ICAN draws on the expertise of its founding members: Assistance Publique Hôpitaux de Paris (AP-HP), Institut National de la Santé et de la Recherche Médicale (INSERM) and Sorbonne Université (SU).
The Board of Directors
The IHU is managed by a Board of Directors, which defines its general policy.
Anne-Marie ARMANTERAS
Chair of the ICAN Board of Directors
A graduate of the Ecole des Hautes Etudes en Santé Publique (EHESP), Anne-Marie Armanteras has worked as the head of a hospital and then as the Île-de-France regional delegate for the Fédération des établissements hospitaliers et d’aide à la personne (FEHAP).
She has also held senior positions in the healthcare system, managing the Healthcare Establishments Division and the Healthcare and Medico-social Services Department of the Île-de-FranceRegional Health Agency (ARS ) from 2013 to 2016 and as Director General of Healthcare Services (DGOS) at the Ministry of Health and Social Affairs from April 2016 to April 2017.
A member of the College of the French National Authority for Health (Haute Autorité de Santé ) in 2017, she was then appointed health adviser on health, disability and the elderly to the President of the Republic, a post she held from March 2020 to June 2022.
She was also appointed in 2023 to propose “a plan to renovate biomedical research” by the ministers of health, industry, higher education and research.
Currently Chair of the Think Tank Health & Tech, she is also Chair of the Board of Directors ofANAP (Agence nationale pour la performance sanitaire et médico-sociale).
Representatives of the founders
Nicolas REVEL
Director General, AP-HP
Didier SAMUEL
Chairman and Chief Executive Officer INSERM
Nathalie DRACH-TEMAM
President, Sorbonne University
Milan LAZAREVIC
Director of Clinical Research and Innovation AP-HP
Elli CHATZOPOULOU
Director of Partnerships and External Relations INSERM
Bruno RIOU
Dean of the Faculty of Medicine
Elisabeth ANGEL PEREZ
Vice-President, in charge of Research and Training Sorbonne Université
Qualified personalities
Catherine BOILEAU
AP-HP – PUPH
Claudine CANALE
President of Les Poids Plume France
Stanislav DUSKO EHRLICH
Director of Research, INRIA
Julien ETTERSPERGER
CEO MEDICEN, Paris Région
Anne-Marie ARMANTERAS
President, Think Tank Health & Tech
Representatives from the business world
Laurence COMTE-ARASSUS
GE Healthcare, Managing Director, FBFA zone, SNITEM representative
Pierre SONIGO
SEBIA, Chief Scientist
Philip JANIAK
Corteria Pharmaceuticals, CEO
Clément LE RUYER
Budget and Academic Legality Controller, DEVU, Paris Education Authority
Representatives of Researchers and Lecturers
Corinne FRERE
MCU-PH, Biological Haematology, AP-HP
Bruno FEVE
CRSA, UMR-S 938
The Executive Committee
The IHU’s Executive Committee (COMEX) is made up of the Director General, the Secretary General, the heads of the IHU’s internal divisions and one community representative per strategic area. The Director of the Pitié-Salpêtrière Hospital Group and the Medical Director of the DMU are permanent guests. The Executive Committee is responsible for assisting the Chief Executive, particularly in defining the IHU’s strategy and scientific guidelines, as well as all aspects of management.
The CEO is appointed for 4 years by the Chairman of the Board of Directors, from candidates proposed by the Board. The Director General is responsible for the overall management of the IHU and is assisted by a Secretary General, who is responsible for the operational management of the Institute.
Prof. Judith ARON-WISNEWSKY
Nutrition Department, Pitié-Salpêtrière Hospital
Prof. Olivier BOURRON
Diabetology Department, Pitié-Salpêtrière Hospital
Julie LAIGRE
Director of Research, Innovation and Rare Diseases, APHP.SU
Prof. Philippe CHARRON
Head of the UMR 1166 Genomics and Physiopathology of Myocardial Diseases research team and Director of the Centre of Reference for Hereditary Cardiomyopathies and Cardiac Rhythm Disorders
Prof. Alain COMBES
Head of Department, Medical Intensive Care, Hôpital Pitié-Salpêtrière
Dr Laurie DUFOUR
Cardiology and vascular diseases
Prof. Bruno FEVE
INSERM U938 – Lipodystrophies, metabolic and hormonal adaptations, and ageing team
Department of Endocrinology, Diabetology and Reproductive Endocrinology, Hôpital Saint-Antoine
Dr Antonio GALLO
Endocrinology and metabolism
Prof. Estelle GANDJBAKHCH
Cardiology and vascular diseases
Prof. Richard ISNARD
Cardiology and vascular diseases
Dr Wilfried LE GOFF
Head of the Systemic and Cellular Lipid Metabolism in Cardiometabolic Diseases team (UMR_S1166)
Prof. Irène NETCHINE
Physiology – Paediatric Functional Explorations
Prof. Vlad RATZIU
Gastro-enterology and hepatology
Prof. Alban REDHEUIL
Cardiovascular imaging
The IHU Board
The IHU Board is made up of the Director General of the IHU, the Secretary General, the Dean of the Faculty of Medicine at Sorbonne University, the directors and team leaders of the UMRs involved in ICAN, the Medical Director of the Archimede DMU, and the heads of the DMU’s departments involved in ICAN’s clinical activities. The Chairman of the IHU Board is the IHU’s Director General. Its purpose is to strengthen the internal cohesion of the IHU’s medical and scientific community and to ensure that information flows smoothly between the teams to ensure overall consistency. The purpose of the IHU Council is to exchange and share information on the strategic orientations and scientific policy of the IHU.
Prof. Zahir AMOURA
Head of the Internal Medicine Department at the Pitié-Salpêtrière Hospital
Elise BALSE
Head of the Molecular and Cellular Plasticity in Cardiovascular Diseases team – UMR 1166
Prof. Philippe CHARRON
Head of the Genomics and Physiopathology of Myocardial Diseases research team – UMR 1166 and Director of the Reference Centre for Hereditary Cardiomyopathies and Cardiac Rhythm Disorders
Prof. Laurent CHICHE
Head of the Cardiovascular Surgery Department at Saint Antoine Hospital
Prof. Sophie CHRISTIN-MAITRE
Head of the Endocrinology, Diabetology and Reproductive Medicine Department at Saint-Antoine Hospital
Prof. Karine CLEMENT
Head of UMR 1269 Nutriomics – Nutrition and Obesity
Prof. Ariel COHEN
Head of Cardiology Department, Saint Antoine Hospital
Dr Michel ZEITOUNI
Head of the Interventional Cardiology Unit at the GH PSL Heart Institute, Head of Team 2 Atherothrombosis and Applied Pharmacology – UMR 1166
Prof. Alain COMBES
Head of the Intensive Care Unit at the Pitié-Salpêtrière Hospital
Prof. Bruno FEVE
Director of Research Unit 938 – Saint-Antoine Research Centre
Fabienne FOUFELLE
Head of the metabolic diseases, diabetes and co-morbidities team – UMR 1138 Cordeliers research centre
Prof. Christian FUNCK-BRENTANO
Head of the Paris-Est Clinical Investigation Centre (CIC)
Professor Agnès HARTEMANN
Head of the IE3M Diabetology Department
Prof. Chantal HOUSSET
Head of the Fibroinflammatory Diseases of Metabolic and Biliary Origin of the Liver team – Research Unit 938 – Saint-Antoine Research Centre
Prof. Richard ISNARD
Head of the ARCHIMEDE DMU
Nadjia KACHENOURA
Cardiovascular Imaging Team Leader UMR 1146
Wilfried LE GOFF
Team Leader, Cellular Lipid Metabolism in Cardiovascular Diseases – UMR 1166
Prof. Camille BUFFET
Head of the Thyroid Pathology and Endocrine Tumour Functional Unit
Prof. Pascal LEPRINCE
Head of the Cardiac Surgery Department at the Pitié-Salpêtrière Hospital Group Heart Institute
Philippe LESNIK
Mononuclear Phagocytes in Metabolic Diseases Team – UMR116
Sophie NADAUD
Head of the Molecular and Cellular Plasticity in Cardiovascular Diseases team – UMR 1166
Prof. Irène NETCHINE
Head of the IGF System, Foetal and Postnatal Growth team – Research Unit 938 – Saint-Antoine Research Centre
Prof. Michel OPPERT
Head of the Nutrition Department at the E3M Institute and the Human Nutrition Research Centre (CRNH)
Prof. Christine POITOU BERNERT
Nutrition – Genetic Rare Obesity Reference Centre
Prof. Alban REDHEUIL
Head of the Cardiovascular Imaging Unit at the Pitié-Salpêtrière Hospital Group Heart Institute
Prof. Bruno RIOU
Dean of the Faculty of Medicine
Professor Anne BACHELOT
Head of the Endocrinology and Reproductive Medicine Department
Prof. Corinne VIGOUROUX
Reference Centre for Rare Pathologies of Insulin Secretion and Insulin Sensitivity (PRISIS)
Prof. Johanne SILVAIN
The Scientific Advisory Board
ICAN’s Scientific Advisory Board is made up of 5 external personalities, highly recognised by the international scientific community, in the field of cardiometabolism and nutrition. This scientific governance body, appointed by the Board of Directors, is consulted on the Institute’s major scientific orientations and annual action programme. The Scientific Advisory Board also assesses the Foundation’s scientific performance. It is very involved in ICAN’s scientific life and plays a fundamental role in it.
Prof. Karin SIPIDO
President of the ICAN Board of Directors
Professor of Medicine and Head of Experimental Cardiology
University of Leuven
Belgium
“ICAN is an ambitious, forward-looking centre of excellence of international stature, at the forefront of cardiometabolic research. This field is highly relevant given the current boom in obesity, diabetes and cardiovascular disease. ICAN has a unique approach, focusing on communication between organs.
The Scientific Advisory Board particularly appreciated the depth and breadth of ICAN’s research, which relies on advanced technology platforms to collect and use a multitude of data, linking basic and clinical research to optimise the application of results. The early and mid-career scientists who attended the meeting highlighted the promising future of ICAN’s mission.ˮ
Prof. Karine SIPIDO, Chair of the Scientific Advisory Board
Prof. André CARPENTIER
Faculty of Medicine and Health Sciences, Université de Sherbrooke
Director of the “Diabetes, Obesity and Cardiovascular Complications” Research Axis
Canada
Professor Michel KOMAJDA
Professor of Cardiology and Chairman of the Heart & Research Foundation
Paris Saint-Joseph Hospital Group, Paris Sorbonne University
France
Dr David SAVAGE
Biochemist-endocrinologist, Biology of fatty tissue
Institute of Metabolic Science, Cambridge University Hospitals
United Kingdom
Prof. Rozemarijn VLIEGENTHART
Radiologist and Professor of Cardiothoracic Imaging
University Medical Centre Groningen
Netherlands
Prof. Arnold VON ECKARDSTEIN
Clinical biochemistry, laboratory medicine and pathology
University Centre for Laboratory Medicine and Pathology (UZL)
Switzerland
Dr Amalia GASTALDELLI
Research Director of Cardiometabolic Risk Unit
Institute of Clinical Physiology, CNR, Pisa Italy
Professor of Medicine-adjunct, UT Health Science Center San Antonio, TX, USA
President of NAFLD study group and the EGIR study group
Italy
Pr Connie BEZZINA
Professor of Experimental Cardiology – Amsterdam University Medical Center
Member of the Royal Netherlands Academy of Arts and Sciences
netherlands
